Gilead Sciences

GILD

Gilead Sciences, Inc. , is an American biopharmaceutical company headquartered in Foster City, California that researches, develops and commercializes drugs. The company focuses primarily on antiviral drugs used in the treatment of HIV, hepatitis B, hepatitis C, and influenza, including Harvoni and Sovaldi. Gilead is a member of the NASDAQ Biotechnology Index and the S&P 500.

Gilead Sciences has been a target of short sellers for a while. The current short interest of 1.63% is roughly at the average of the last 12 months (1.78%).